Embecta (EMBC) reported fiscal Q4 adjusted earnings Tuesday of $0.45 per diluted share, down from $0.59 a year earlier.
Analysts polled by FactSet expected $0.36.
Revenue for the quarter ended Sept. 30 was $286.1 million, down from $281.9 million a year earlier.
Four analysts surveyed by FactSet expected $277 million
For fiscal 2025, the medical supplies company expects adjusted EPS of $2.70 to $2.90 on revenue of $1.09 billion to $1.11 billion. Analysts polled by FactSet expect non-GAAP EPS of $2.27 on revenue of $1.12 billion.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。